Business Description
Apollon Formularies PLC
ISIN : IM00BJ0LRD77
Description
Apollon Formularies PLC is a London, England and Jamaican based medical cannabis pharmaceutical company specialising in research and treatment of patients with cancer and chronic pain. It is engaged in investing by seeking to acquire a direct and/or indirect interest in projects and assets in the agriculture and logistics sectors and the medicinal cannabis sector. The company focus on opportunities in Africa and Europe. It has created proprietary hybrid medical cannabis pharmaceutical strains, technology, formulations, and treatment products.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.53 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 3.77 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 39.9 | |||||
| 3-Year EPS without NRI Growth Rate | 47.7 | |||||
| 3-Year FCF Growth Rate | 37.9 | |||||
| 3-Year Book Growth Rate | -67.8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 9-Day RSI | 32.17 | |||||
| 14-Day RSI | 38.13 | |||||
| 6-1 Month Momentum % | -50 | |||||
| 12-1 Month Momentum % | -50 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.6 | |||||
| Quick Ratio | 0.6 | |||||
| Cash Ratio | 0.03 | |||||
| Days Sales Outstanding | 5026.35 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -260.8 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -839.58 | |||||
| Net Margin % | -1591.67 | |||||
| FCF Margin % | -64.29 | |||||
| ROE % | -29.66 | |||||
| ROA % | -20.07 | |||||
| ROIC % | -13.71 | |||||
| 3-Year ROIIC % | -86.71 | |||||
| ROC (Joel Greenblatt) % | -235.21 | |||||
| ROCE % | -15.64 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.03 | |||||
| EV-to-EBIT | -2.66 | |||||
| EV-to-EBITDA | -2.66 | |||||
| EV-to-Revenue | 22.33 | |||||
| EV-to-FCF | -34.58 | |||||
| Earnings Yield (Greenblatt) % | -37.59 | |||||
| FCF Yield % | -2.76 |
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers